Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 6;10(7):1083.
doi: 10.3390/vaccines10071083.

Transplacental Transfer of Maternal Antibody against SARS-CoV-2 and Its Influencing Factors: A Review

Shuang Liu  1 , Jiayi Zhong  1 , Dingmei Zhang  1
Affiliations
Review

Transplacental Transfer of Maternal Antibody against SARS-CoV-2 and Its Influencing Factors: A Review

Shuang Liu et al. Vaccines (Basel). .

Abstract

Since the beginning of the coronavirus disease 2019 (COVID-19) outbreak, the disease has rapidly become a global threat. The constant emergence of new variants has increased the difficulty of controlling this disease. Vaccination is still considered the most effective method to prevent COVID-19. Vaccination has expanded to include children aged 3-17 years old, and some countries have lowered the age of vaccination to 6 months (for example, the United States). However, children under 3 years old are still not able to be vaccinated in most countries. In this study, we summarize the COVID-19 vaccination status in pregnant women, comprehensively elaborate on the status of maternal immune response and maternal antibody transfer after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and vaccination, and further analyze the possible influencing factors of maternal antibody transfer according to the currently available evidence on the topic. It was concluded that pregnant women develop an immune response and produce antibodies that can be transmitted through the placenta after vaccination, but more data are needed to determine the transfer rate and duration of these maternal antibodies and potential factors. The results provide a scientific basis for studying the protective effect of maternal antibodies on infants, formulating a vaccination strategy for pregnant women, and preventing SARS-CoV-2 infection in infants.

Keywords: COVID-19 vaccine; antibodies transfer; maternal antibody; pregnancy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. World Health Organization WHO Coronavirus (COVID-19) Dashboard. [(accessed on 17 April 2022)]. Available online: https://covid19.who.int/table.
    1. Li L., Wu L., Yin X., Li C., Hua Z. Current Situation and New Ideas of SARS-CoV-2 Vaccine Research and Development. Pharm. Biotechnol. 2021;28:395–399. doi: 10.19526/j.cnki.1005-8915.20210413. - DOI
    1. Thomas S.J., Moreira E.D., Jr., Kitchin N., Absalon J., Gurtman A., Lockhart S., Perez J.L., Marc G.P., Polack F.P., Zerbini C. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months. N. Engl. J. Med. 2021;385:1761–1773. doi: 10.1056/NEJMoa2110345. - DOI - PMC - PubMed
    1. Li X.N., Huang Y., Wang W., Jing Q.L., Zhang C.H., Qin P.Z., Guan W.J., Gan L., Li Y.L., Liu W.H. Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: A test-negative case-control real-world study. Emerg. Microbes Infect. 2021;10:1751–1759. doi: 10.1080/22221751.2021.1969291. - DOI - PMC - PubMed
    1. COVID-19: Pfizer, BioNTech Say Booster Restores Full Protection. [(accessed on 17 April 2022)]. Available online: https://www.chinadailyhk.com/article/243948.

LinkOut - more resources